Skip to main content
Curiox Biosystems Co., Ltd. logo

Curiox Biosystems Co., Ltd. — Investor Relations & Filings

Ticker · 445680 ISIN · KR7445680002 KO Manufacturing
Open in API
Filings indexed 130 across all filing types
Latest filing 2023-07-24 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 445680

About Curiox Biosystems Co., Ltd.

https://www.curiox.com/

Curiox Biosystems is a life science technology company that develops and manufactures automated solutions for cell sample preparation. The company specializes in centrifuge-free technologies designed to standardize and improve workflows for cell analysis. Its core C-FREE™ technology utilizes a gentle, laminar flow-based washing method that replaces traditional centrifugation. This approach minimizes cell stress and loss, thereby enhancing cell retention, viability, and the quality of downstream analytical data. Curiox's product portfolio includes the Pluto series of automated liquid handling workstations and associated consumables. These systems automate critical steps such as cell washing, antibody staining, and antibody cocktailing for applications including flow cytometry, single-cell sequencing, and multiplex immunoassays, supporting research with various sensitive cell types.

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) filed by Curiox Biosystems. It explicitly mentions multiple 'Correction' (정정) filings, indicating it is an amendment to a previously submitted registration statement for an IPO (Initial Public Offering). In the context of financial filings, a registration statement for a public offering is a primary regulatory document that details the company's business, financial risks, and offering terms. Since it is a formal regulatory filing submitted to the financial authorities (FSS/DART) and does not fit into the specific categories like 'Annual Report' or 'Earnings Release', it is classified as a Regulatory Filing.
2023-07-24 Korean
[기재정정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권)' (Securities Registration Statement for Equity Securities) filed by Curiox Biosystems. It explicitly mentions being a '정정신고' (Amendment) to a previously filed Securities Registration Statement. This type of document is a formal regulatory filing required for public offerings (IPO or capital raising) in South Korea, which falls under the category of regulatory filings for securities registration.
2023-07-14 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고' (Securities Registration Statement Amendment) filed by Curiox Biosystems. It details changes to the public offering schedule, including dates for demand forecasting, subscription, and payment, as well as updates to investment risk factors and financial information. This is a formal regulatory filing related to an IPO process, which falls under the 'Regulatory Filings' category as it is a specific legal document for securities registration.
2023-07-04 Korean
증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) in South Korea. It details the company's intent to offer shares (IPO), provides comprehensive risk factors, financial information, and management details. This is a formal regulatory filing for a public offering, which falls under the 'Regulatory Filings' category as it is a primary registration document for securities.
2023-06-16 Korean
감사보고서 (2022.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Curiox Biosystems Co., Ltd. for the fiscal year ending December 31, 2022. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a comprehensive financial document, not an announcement of a report, and fits the definition of an Audit Report/Information (AR). FY 2022
2023-04-06 Korean
연결감사보고서 (2022.12)
Audit Report / Information Classification · 100% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for Curiox Biosystems, covering the fiscal years 2021 and 2022. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. This is a comprehensive financial report for a specific period, which aligns with the definition of an Audit Report (AR) or Financial Report. Given the explicit inclusion of the 'Independent Auditor's Report' and the detailed financial statements, it is classified as an Audit Report. FY 2022
2023-04-06 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.